Skip to main content
Robert Bast Jr., MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

RobertClintonBastJr.MD

Oncology • Houston, TX

Breast Cancer, Gynecologic Cancer

Professor of Medicine, University Tex MD Anderson Cancer Center Houston

Join to view full profile

Dr. Bast is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bast's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1977
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1976
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 1971 - 1972
  • Harvard Medical School
    Harvard Medical SchoolClass of 1971

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 1994 - 2025
  • MA State Medical License
    MA State Medical License 1976 - 2025
  • TN State Medical License
    TN State Medical License 2023 - 2025
  • WA State Medical License
    WA State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Whos Who in United States Marquis Whos Who
  • Fellow American Scocirty of Clinical Oncology, 2017
  • Fellow American Association for the Advancement of Science, 2002
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Paclitaxel Sensitivity of Ovarian Cancer Can Be Enhanced by Knocking down Pairs of Kinases That Regulate MAP4 Phosphorylation and Microtubule Stability  
    Robert C Bast, Anil K Sood, Clinical Cancer Research

Press Mentions

  • Green3Bio Announces Publication of Pre-Clinical Data Demonstrating SIK2 Inhibition (Including GRN-300) Enhances PARP Inhibitor Activity Synergistically in Ovarian and Triple Negative Breast Cancers
    Green3Bio Announces Publication of Pre-Clinical Data Demonstrating SIK2 Inhibition (Including GRN-300) Enhances PARP Inhibitor Activity Synergistically in Ovarian and Triple Negative Breast CancersJune 24th, 2022
  • MD Anderson Receives $55 Million over Five Years in Comprehensive Cancer Center Status Renewal
    MD Anderson Receives $55 Million over Five Years in Comprehensive Cancer Center Status RenewalAugust 22nd, 2019
  • NFCR Fellow Susan Band Horwitz Named Giant of Cancer Care
    NFCR Fellow Susan Band Horwitz Named Giant of Cancer CareJune 3rd, 2019
  • Join now to see all

Grant Support

  • The University Of Texas M. D. Anderson Cancer Center Spore In Ovarian CancerNational Cancer Institute2010–2011
  • P1 - Early Detection Of Epithelial Ovarian CancerNational Cancer Institute2010–2011
  • ARHI (Diras 3) In Autophagy And Dormancy Of Ovarian CancerNational Cancer Institute2009–2011
  • PAUL Calabresi Clinical Oncology AwardNational Cancer Institute2005–2011
  • Early Detection Of Epithelial Ovarian CancerNational Cancer Institute2008–2009
  • University Of Texas MD Anderson Spore In Ovarian CancerNational Cancer Institute2000–2009
  • Developmental Research ProgramNational Cancer Institute1999–2009
  • Career Development ProgramNational Cancer Institute1999–2009
  • Clinical Oncology Research Career Development ProgramNational Cancer Institute2000–2004
  • Specific Immunotherapy With Monoclonal AntibodiesNational Cancer Institute1995–2004
  • Training For Academic OncologyNational Cancer Institute1999–2003
  • Core--Planning And EvaluationNational Cancer Institute2001–2002
  • ARHI: An Imprinted Tumor Suppressor GeneNational Cancer Institute2001–2002
  • Chemoprevention Of Ovarian Cancer With Fenretinide And Oral ContraceptivesNational Cancer Institute1999–2002
  • Chemoprevention Of Ovarian Cancer In Women Using Fenretinide/Oral ContraceptivesNational Cancer Institute1999–2002
  • Y2, A Novel Ovarian Cancer Tumor Suppressor GeneNational Cancer Institute1998–2000
  • Spore In Ovarian CancerNational Cancer Institute1999
  • Training For Academic Oncology/HematologyNational Cancer Institute1996–1998
  • Core--Developmental FundsNational Cancer Institute1996–1998
  • Immunodetection And Immunopharmacologic Elimination Of Breast/Ovarian CancerNational Cancer Institute1996–1997
  • Training For Academic Oncology/HematologyNational Cancer Institute1995
  • Clinical Cancer Research ProgramNational Cancer Institute1985

Committees

  • Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships

Hospital Affiliations

Dr. Robert Bast, Dr. Robert Bast, MD, Dr. R Bast, Dr. Robert Clinton Bast